The toll at home had begun even earlier with deaths of children reported as early as 2019

xIt is a sordid tale of greed and lax governance that allowed Indian cough syrups to be sold freely after some of their formulations came under a cloud almost three years ago with multiple deaths of young children in different countries like The Gambia, Uzbekistan and Iraq. The toll at home had begun even earlier with deaths of children reported as early as 2019.

Not even the most recent deaths — of at least 14 children in the states of Maharashtra, Rajasthan and Madhya Pradesh — seem to have stirred the conscience of the drug maker, people in the supply chain and doctors who have been prescribing the cough syrup from a particular manufacturer in Tamil Nadu near Chennai despite an alert having been

See Full Page